Sage Journals: Discover world-class research

Open access

Research article

First published 2024

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam

Van Luan Pham, Tuan Anh Le, Cam Phuong Pham [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2020-6

Successful treatment of a patient with NSCLC carrying uncommon compound EGFR G719X and S768I mutations using osimertinib: A case report

Yangyang Cai, Yizhuo Wang, Jingnan Sun [...]

Journal of International Medical Research

Open access

Research article

First published 2025-09

Real-World Evidence for First-Line afatinib in Advanced Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations Other than G719X/L861Q/S768I

Thanh Ha Vu, Hoa Thai Thi Nguyen, To Van Ta [...]

Cancer Control

Open access

Research article

First published 2025

Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam

Van Luan Pham, Cam Phuong Pham, Thi Thai Hoa Nguyen [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2019

First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the ‘real-world’ clinical setting

Keunchil Park, Darren Wan-Teck Lim, Isamu Okamoto [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2020

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

Shang-Gin Wu, Chong-Jen Yu, James Chih-Hsin Yang [...]

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2016-6

Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidence

E-E Ke, Yi-Long Wu

Therapeutic Advances in Respiratory Disease

Retricted access

Case report

First published 2018-4

Concomitant Presence of EGFR and ALK Fusion Gene Mutation in Adenocarcinoma of Lung: A Case Report and Review of the Literature

Nishitha Thumallapally, Hana Yu, Mohammad Farhan [...]

Journal of Pharmacy Practice

Open access

Review article

First published 2020-9

Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings

R Donald Harvey, Val R Adams, Tyler Beardslee [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024-06

Evaluating the Clinical Characteristics and Prognosis of Advanced Non-Small Cell Lung Cancer with Exon 20 Insertions

Haibo Wang, Yiquan Xu, Jinlan Lin [...]

Cancer Control

Search results